Bovine Plasma Market - Insights for Business Growth Report 2024-2032

Bovine Plasma Market Synopsis:

Bovine Plasma Market Size Was Valued at USD 1.56 Billion in 2023 and is Projected to Reach USD 2.31 Billion by 2032, Growing at a CAGR of 5.3% From 2024-2032.

Bovine plasma refers to plasma produced from blood collected from cows and it contains proteins, growth factors, and immunoglobulins. Bovine plasma is a very versatile product that finds application in a variety of sectors such as biotechnology, pharmaceuticals feeding and elanchem, and cosmetics. It is widely used in the manufacture of cell culture media for biotechnological products and vaccines in the biotechnology and pharmaceutical industries. Furthermore, its regenerative quality makes it popular in cosmetic production as well as in aromatherapy. They are main driven by the increasing consumption in these sectors and augmenting plasma processing technology and the increasing global consumption of biologics and animal products.

The market for the bovine plasma is still relatively young, yet rapidly growing as it finds its uses in a wide range of industries including biotechnology, pharmaceutics, animal feed production, and cosmetic industries. In the biotechnology and pharmaceutical industries, bovine plasma is widely used in the manufacturing of cell culture media, a critical element particularly in the generation of bio-logistics, vaccines and therapeutic proteins. The market for biologics, development in the vaccines market, and the ongoing progression of the idea of ‘personalised medicine’ is helping drive the demand for bovine plasma further. Moreover, the use of bovine plasma in the manufacture of vaccines for some diseases such as foot-and-mouth diseases and bovine tuberculosis is on the rise. This is made worse by growing demands for high precision diagnostic reagents and therapeutic products, which in turn escalates usage of plasma derived proteins, in utilization and analysis. Consequently, in animal nutrition, bovine plasma is used as indispensable component of high-protein feed for animals as well as an added source of valuable nutrients, proteins and some amino acids which are important for the growth, immunity and general well-being of animals. The knowledge of Bovine plasma as an essential part of commercial feed and its utilization on an expanding basis in livestock raising, especially in the face of increasing per capita intake of meat all over the world particularly in the developing countries, make bovine plasma an important ingredient that cannot be completely relegated to the sidelines of modern farming technology.

Furthermore, the application of the bovine plasma is increasing popularity in the cosmetics and personal care segment because of its re-generation and re-vitalization characteristic. Recent years, it is included in compositions of anti-aging cosmetics, care products for face and body, focusing on firmness and moisture. This is with the increasing concern of consumers in natural and biological active substances in cosmetics. Recent advancements in technology for example in plasma processing are improving methods in extraction of plasma, plasmid purification, and plasma fractionation leading to the improvement in yield of bovine plasma products hence expanding its uses and availability. Due to this reason, the market is today characterised by more firms undertaking research activities to seek new applications for bovine plasma. However, the market that it has for its products has its problems like ethical issues that have to do with animal right violation and the changing legislation on those matters and such. Other factors that may also slow the growth of the market include high levels of regulation of bovine plasma for use as an ingredient in pharmaceuticals and food items around the world. However, the increasing uses of bovine plasma in biotechnology uses, animal feed supplements, cosmetic products, and other applications combined with the further development of processing techniques to process raw materials are estimated to encourage the market in the future years.

Bovine Plasma Market Trend Analysis:

Increasing Demand for High-Quality Biologics and Vaccine

• The increasing consumption of biotherapeutic products such as biologics and vaccines around the world is one of the stimulus that is driving the bovine plasma market. Bovine plasma is widely used in the formulation of cell culture media, which form the basis for the culture of cells employed in making biologics, including monoclonal antibodies and therapeutic proteins, as well as vaccines. In recent years the use of Biologics has gained importance in the population as the global demography is aging and the rates of chronic problems like cancer, diabetes and autoimmune disorders are on the rise . This is important to the Biologic Manufacture because bovine plasma is needed to support the growth and maintenance of mammalian cell lines, which are used as a substrate in the cumulative biologics development.
• Additionally, need of vaccine especially in light of emerging or new strains of any particular disease is also another contributing factor towards this market. Vaccines – human and animal health vaccines, flu or COVID or vaccines for diseases of cattle and other livestock involve bovine plasma of high quality to culture the virus or bacteria for production. Immunoglobulins present in the bovine plasma are quite valuable because these proteins are dominant in the creation of vaccines. The extension of the vaccination campaigns all over the world and especially after the world and regional health crises like COVID-19 infection has also supplemented the demand for plasma derived products. As new and more vaccines for humans and animals come in the development both for production and research it is evident that bovine plasma will remain relevant more so in the coming years across the biopharmaceutical industries. This ever rising requirement for innovative, high-quality, biologics and vaccines is expected to put the bovine plasma market at the next level in the coming years

Growing Global Demand for High-Quality Animal Protein Boosts Bovine Plasma Use in Livestock Feed

• Poultry, swine and aqua products are expanding the use of bovine plasma in livestock feed due to the global demand of high quality animal proteins. Today, people from all over the world consume more proteins than before and with the world’s population continuing to increase, today’s farming techniques remain unsustainable. Currently, bovine plasma has proved to be endowed with nutritive value, valuable amino acids, growth factors as well as immunoglobulins making it an approved supplement in animal diets that enhance feeds’ value in regard to growth and immune system among many live stock. The above trend is particularly significant in areas where demand for animal products is increasing at a fastest rate; like the Asia-Pacific and Latin America regions.
• Livestock producers are aware that the consumers are becoming more concerned with the quality, safety, and source of foods of animal origin; as a result they are using the bovine plasma in production because it is safe and effective feed ingredient. The integration of cassava in feed form not only increases efficiency in feed intake but also results to better performance of the livestock mainly the meat quality and healthy live stocks. Since the new techniques in animal production pay more attention to the quality of feeds, the need for better quality ingredients such as bovine plasma is likely to increase in future. The growing incorporation of bovine plasma with animal feed presents significant opportunities for market participants because it is consistent with trends towards healthier animal production and better-quality animal proteins.

Bovine Plasma Market Segment Analysis:

Bovine Plasma Market is Segmented on the basis of Type, Application, End User, and Region

By Type, Defibrinated Bovine Plasma segment is expected to dominate the market during the forecast period

• The segment of Defibrinated Bovine Plasma is expected to hold majority market share in the bovine plasma market in the forecast period. For clarity, there is defibrinated plasma, which is plasma to which fibrinogen has been removed so that it does not clot; this type of plasma is much valued because it contains nutrients and growth factors. This makes it suitable when used in cell culture media biology which forms the basis in developing the biopharmaceutical products such as vaccines atp monoclonal antibodies and therapeutic proteins. As the world’s demand for biologic drugs and vaccines for diseases stands as well as confronting the constantly increasing incidence of chronic diseases, the defibrinated bovine plasma remains the essential ingredient for culturing of corresponding cells.
• The defibrinated plasma is also very popular in the animal feeding, especially in livestock feeding, because the product contains many proteins such as immunoglobulins and amino acids that helps improve the growth, immune status, and productivity of the animal. As the global consumption of premium meat and conscious farming trends rise, the additive property of defibrinated bovine plasma in animal nutrition will continue to boost its saturated market leadership. Owing to its vast uses in biopharmaceuticals as well as animal nutrition the defibrinated bovine plasma segment will continue to be the largest and most dominant segment of the bovine plasma market during the forcast period.

By Application, Biotechnology and Pharmaceutical Applications segment expected to held the largest share

• The top three applications are Biotechnology and Pharmaceutical Applications, Diagnostics and Research and Medical Applications; it is projected that Biotechnology and Pharmaceutical Applications will constitute the greater proportion of the bovine plasma demand during the forecast period. This dominance is due to the highest importance of the bovine plasma in the biopharmaceutical industry especially in the preparation of cell culture media required in the advancement and production of vaccines, monoclonal antibodies, therapeutic proteins, and other related biologic drugs. Bovine plasma contains important growth factors, nutrients, and proteins which are used to culture mammalian cells in the laboratory needed for the synthesis of complex biosimilars and vaccines.
• As the world seeks newer therapies to meet the growing prevalence of chronic diseases, cancer, autoimmune disorders, and the move towards individualized treatment, the world demands high quality bovine plasma to manufacture these brands. The focused product development area of immunotherapy, biologics, and gene therapies extends the use of specialized cell culture media in the pharmaceutical industry, guaranteeing that the biotechnology and pharmaceutical applications segment will have the largest share of the market. Also with the increasing health issues around the world and subsequent concern for vaccines, the segments of human and veterinary vaccines are expected to propel this segment of the market ahead.

Bovine Plasma Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America is anticipated to have the largest share in Bovine Plasma Market during the forecast period, because of its developed biotechnology and pharmaceutical markets, increasing demand for biologics and well developed agriculture and livestock markets. United States and Canada has the high density of pharmaceutical companies, vaccine manufacturers, and biotech firm to utilize the Bovine plasma as raw material for cell culture media used in the production of vaccines, therapeutic proteins and other biologics. It also occupies some of the greatest animal feed producers that incorporate bovine plasma as an important ingredient in an endeavor to improve the animals health, growth and production.
• In addition, advanced research infrastructure, good regulatory environment, and growing focus on personalized medicine and immunotherapy in North America also add to the developments of high quality of bovine plasma. Awareness towards conservation across the farming practices is expanding as consumers prefer animal protein; these are essential drivers that influence the uptake of bovine plasma in animal feeds. Forums on biopharmaceutical prominence state that North America remains at the forefront of vaccine as well as biologic development hence the growing demand for defibrinated bovine plasma and other plasma derivatives will ensure the geographical area under review retains the leading position within bovine plasma market.

Active Key Players in the Bovine Plasma Market:

• Abcam (United Kingdom)
• Baxter International Inc. (United States)
• Bovogen Biologicals (Australia)
• China National Pharmaceutical Group (Sinopharm) (China)
• Cohn & Borthers (United States)
• Green Mountain Plasma (United States)
• Grifols S.A. (Spain)

• Intermountain BioMedical (United States)

• LBD (Lachlan Bovine Derivatives) (Australia)
• Lonza Group Ltd. (Switzerland)
• Merck KGaA (Germany)
• PeproTech, Inc. (United States)
• Plasmapheresis (United States)
• SeraCare Life Sciences, Inc. (United States)
• Sichuan Deebio Pharmaceutical Co. Ltd. (China)
• Sigma-Aldrich (Merck) (United States)
• Thermo Fisher Scientific Inc. (United States)
• Vital Proteins (United States), and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Bovine Plasma Market by Type
 4.1 Bovine Plasma Market Snapshot and Growth Engine
 4.2 Bovine Plasma Market Overview
 4.3 Defibrinated Bovine Plasma
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Defibrinated Bovine Plasma: Geographic Segmentation Analysis
 4.4 Hyperimmune Plasma
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Hyperimmune Plasma: Geographic Segmentation Analysis
 4.5 Fresh Frozen Plasma
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Fresh Frozen Plasma: Geographic Segmentation Analysis
 4.6 Fractionated Plasma Products
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Fractionated Plasma Products: Geographic Segmentation Analysis

Chapter 5: Bovine Plasma Market by Application
 5.1 Bovine Plasma Market Snapshot and Growth Engine
 5.2 Bovine Plasma Market Overview
 5.3 Biotechnology and Pharmaceutical Applications
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Biotechnology and Pharmaceutical Applications: Geographic Segmentation Analysis
 5.4 Animal Nutrition
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Animal Nutrition: Geographic Segmentation Analysis
 5.5 Cosmetics and Personal Care
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Cosmetics and Personal Care: Geographic Segmentation Analysis

Chapter 6: Bovine Plasma Market by End User
 6.1 Bovine Plasma Market Snapshot and Growth Engine
 6.2 Bovine Plasma Market Overview
 6.3 Biopharmaceutical and Biotechnology Companies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Biopharmaceutical and Biotechnology Companies: Geographic Segmentation Analysis
 6.4 Animal Feed Manufacturers
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Animal Feed Manufacturers: Geographic Segmentation Analysis
 6.5 Cosmetics Companies
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Cosmetics Companies: Geographic Segmentation Analysis
 6.6 Research Institutions and Academic Organizations
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Research Institutions and Academic Organizations: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Bovine Plasma Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions  
 7.2 ABCAM (UNITED KINGDOM)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 BAXTER INTERNATIONAL INC. (UNITED STATES)
 7.4 BOVOGEN BIOLOGICALS (AUSTRALIA)
 7.5 CHINA NATIONAL PHARMACEUTICAL GROUP (SINOPHARM) (CHINA)
 7.6 COHN & BORTHERS (UNITED STATES)
 7.7 GREEN MOUNTAIN PLASMA (UNITED STATES)
 7.8 GRIFOLS S.A. (SPAIN)
 7.9 INTERMOUNTAIN BIOMEDICAL (UNITED STATES)
 7.10 LBD (LACHLAN BOVINE DERIVATIVES) (AUSTRALIA)
 7.11 LONZA GROUP LTD. (SWITZERLAND)
 7.12 MERCK KGAA (GERMANY)
 7.13 PEPROTECH INC. (UNITED STATES)
 7.14 PLASMAPHERESIS (UNITED STATES)
 7.15 SERACARE LIFE SCIENCES INC. (UNITED STATES)
 7.16 SICHUAN DEEBIO PHARMACEUTICAL CO. LTD. (CHINA)
 7.17 SIGMA-ALDRICH (MERCK) (UNITED STATES)
 7.18 THERMO FISHER SCIENTIFIC INC. (UNITED STATES)
 7.19 VITAL PROTEINS (UNITED STATES)
 7.20 OTHER ACTIVE PLAYERS

Chapter 8: Global Bovine Plasma Market By Region
 8.1 Overview
 8.2. North America Bovine Plasma Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 Defibrinated Bovine Plasma
  8.2.4.2 Hyperimmune Plasma
  8.2.4.3 Fresh Frozen Plasma
  8.2.4.4 Fractionated Plasma Products
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Biotechnology and Pharmaceutical Applications
  8.2.5.2 Animal Nutrition
  8.2.5.3 Cosmetics and Personal Care
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Biopharmaceutical and Biotechnology Companies
  8.2.6.2 Animal Feed Manufacturers
  8.2.6.3 Cosmetics Companies
  8.2.6.4 Research Institutions and Academic Organizations
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Bovine Plasma Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 Defibrinated Bovine Plasma
  8.3.4.2 Hyperimmune Plasma
  8.3.4.3 Fresh Frozen Plasma
  8.3.4.4 Fractionated Plasma Products
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Biotechnology and Pharmaceutical Applications
  8.3.5.2 Animal Nutrition
  8.3.5.3 Cosmetics and Personal Care
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Biopharmaceutical and Biotechnology Companies
  8.3.6.2 Animal Feed Manufacturers
  8.3.6.3 Cosmetics Companies
  8.3.6.4 Research Institutions and Academic Organizations
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Russia
  8.3.7.2 Bulgaria
  8.3.7.3 The Czech Republic
  8.3.7.4 Hungary
  8.3.7.5 Poland
  8.3.7.6 Romania
  8.3.7.7 Rest of Eastern Europe
 8.4. Western Europe Bovine Plasma Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 Defibrinated Bovine Plasma
  8.4.4.2 Hyperimmune Plasma
  8.4.4.3 Fresh Frozen Plasma
  8.4.4.4 Fractionated Plasma Products
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Biotechnology and Pharmaceutical Applications
  8.4.5.2 Animal Nutrition
  8.4.5.3 Cosmetics and Personal Care
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Biopharmaceutical and Biotechnology Companies
  8.4.6.2 Animal Feed Manufacturers
  8.4.6.3 Cosmetics Companies
  8.4.6.4 Research Institutions and Academic Organizations
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 The Netherlands
  8.4.7.5 Italy
  8.4.7.6 Spain
  8.4.7.7 Rest of Western Europe
 8.5. Asia Pacific Bovine Plasma Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 Defibrinated Bovine Plasma
  8.5.4.2 Hyperimmune Plasma
  8.5.4.3 Fresh Frozen Plasma
  8.5.4.4 Fractionated Plasma Products
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Biotechnology and Pharmaceutical Applications
  8.5.5.2 Animal Nutrition
  8.5.5.3 Cosmetics and Personal Care
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Biopharmaceutical and Biotechnology Companies
  8.5.6.2 Animal Feed Manufacturers
  8.5.6.3 Cosmetics Companies
  8.5.6.4 Research Institutions and Academic Organizations
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Bovine Plasma Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 Defibrinated Bovine Plasma
  8.6.4.2 Hyperimmune Plasma
  8.6.4.3 Fresh Frozen Plasma
  8.6.4.4 Fractionated Plasma Products
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Biotechnology and Pharmaceutical Applications
  8.6.5.2 Animal Nutrition
  8.6.5.3 Cosmetics and Personal Care
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Biopharmaceutical and Biotechnology Companies
  8.6.6.2 Animal Feed Manufacturers
  8.6.6.3 Cosmetics Companies
  8.6.6.4 Research Institutions and Academic Organizations
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkiye
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Bovine Plasma Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 Defibrinated Bovine Plasma
  8.7.4.2 Hyperimmune Plasma
  8.7.4.3 Fresh Frozen Plasma
  8.7.4.4 Fractionated Plasma Products
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Biotechnology and Pharmaceutical Applications
  8.7.5.2 Animal Nutrition
  8.7.5.3 Cosmetics and Personal Care
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Biopharmaceutical and Biotechnology Companies
  8.7.6.2 Animal Feed Manufacturers
  8.7.6.3 Cosmetics Companies
  8.7.6.4 Research Institutions and Academic Organizations
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research